Elimination of palmitoylation sites in the human dopamine D-1 receptor does not affect receptor-G protein interaction

被引:27
作者
Jin, H
Zastawny, R
George, SR
ODowd, BF
机构
[1] UNIV TORONTO, DEPT PHARMACOL, TORONTO, ON M5S 1A8, CANADA
[2] UNIV TORONTO, DEPT MED, TORONTO, ON M5S 1A8, CANADA
[3] ADDICT RES FDN, TORONTO, ON M5S 2S1, CANADA
基金
英国医学研究理事会;
关键词
dopamine; dopamine D-1 receptor; palmitoylation; adenylyl cyclase; desensitization;
D O I
10.1016/S0014-2999(97)00059-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We have eliminated putative palmitoylation sites in the carboxyl tail of the human dopamine D-1 receptor by replacing the two cysteine residues with alanines either separately or together. The wild type and the three mutated dopamine D-1 receptors were stably expressed in baby hamster kidney cells and characterized to detect any resulting alterations in receptor-G protein interactions. The three mutant dopamine D-1 receptors retained the same proportion of high affinity state for agonists as wild type receptors and also no difference was observed in the stimulation of adenylyl cyclase activity. Our results are in contrast to those observed with the beta(2)-adrenoceptor and consistent with similar studies of luteinizing hormone/human chorionic gonadotropin (LH/hCG) receptors, alpha(2)-adrenoceptors, muscarinic M-2 receptors and thyrotropin releasing hormone (TRH) receptors. Thus, we suggest that palmitoylation appears to play a unique role in the beta(2)-adrenoceptors, and appears not to be essential in G protein coupling for the dopamine D-1 receptors. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:109 / 116
页数:8
相关论文
共 27 条
[1]   OVERVIEW - PROTEIN PALMITOYLATION IN THE NERVOUS-SYSTEM - CURRENT VIEWS AND UNSOLVED PROBLEMS [J].
BIZZOZERO, OA ;
TETZLOFF, SU ;
BHARADWAJ, M .
NEUROCHEMICAL RESEARCH, 1994, 19 (08) :923-933
[2]  
BONATTI S, 1989, J BIOL CHEM, V264, P12590
[3]   PALMITOYLATION OF G-PROTEIN-COUPLED RECEPTORS - A DYNAMIC MODIFICATION WITH FUNCTIONAL CONSEQUENCES [J].
BOUVIER, M ;
MOFFETT, S ;
LOISEL, TP ;
MOUILLAC, B ;
HEBERT, T ;
CHIDIAC, P .
BIOCHEMICAL SOCIETY TRANSACTIONS, 1995, 23 (01) :116-120
[4]  
DELEAN A, 1980, J BIOL CHEM, V255, P7108
[5]  
DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653
[6]   THE PALMITOYLATED CYSTEINE OF THE CYTOPLASMIC TAIL OF ALPHA(2A)-ADRENERGIC RECEPTORS CONFERS SUBTYPE-SPECIFIC AGONIST-PROMOTED DOWN-REGULATION [J].
EASON, MG ;
JACINTO, MT ;
THEISS, CT ;
LIGGETT, SB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (23) :11178-11182
[7]   A GENERAL-METHOD OF INVITRO PREPARATION AND SPECIFIC MUTAGENESIS OF DNA FRAGMENTS - STUDY OF PROTEIN AND DNA INTERACTIONS [J].
HIGUCHI, R ;
KRUMMEL, B ;
SAIKI, RK .
NUCLEIC ACIDS RESEARCH, 1988, 16 (15) :7351-7367
[8]   FUNCTIONAL IMPORTANCE OF THE CARBOXYL TAIL CYSTEINE RESIDUES IN THE HUMAN D-1 DOPAMINE-RECEPTOR [J].
JENSEN, AA ;
PEDERSEN, UB ;
KIEMER, A ;
DIN, N ;
ANDERSEN, PH .
JOURNAL OF NEUROCHEMISTRY, 1995, 65 (03) :1325-1331
[9]  
JOHNSON RA, 1991, METHOD ENZYMOL, V195, P3
[10]   PALMITOYLATION OF BOVINE OPSIN AND ITS CYSTEINE MUTANTS IN COS CELLS [J].
KARNIK, SS ;
RIDGE, KD ;
BHATTACHARYA, S ;
KHORANA, HG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (01) :40-44